Fig. 5From: High serum proteinase-3 levels predict poor progression-free survival and lower efficacy of bevacizumab in metastatic colorectal cancerPRTN3 expression in immune cells in the tumor microenvironment. Representative immunofluorescence images of PRTN3 (green), CD66b (red), CD68 (red), CD3 (red), nuclei (blue), and merge (yellow) in the primary tissue. Scale bar: 100 µm. Abbreviations: PRTN3, proteinase-3Back to article page